Recent research has also begun Discovering potential neuroprotective results of GLP-1 receptor agonists, with some studies suggesting achievable Added benefits in conditions like Alzheimer's sickness and Parkinson's illness, even though these programs continue to be investigational at present46.Wegovy® – This can be a higher dose Model of copyri